Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Trophix-Children's Hospital neurodegeneration research collaboration

Nov. 8, 1996

Histamine H3 receptor ligands described by INSERM/Bioprojet

Nov. 8, 1996

Mylan generic drug approved by FDA

Nov. 8, 1996

ImmuLogic's MS therapeutic nearing the clinic

Nov. 8, 1996

FDA approval for Faulding generic anticonvulsant

Nov. 8, 1996

Nicotine analogues proposed for treatment of depression

Nov. 8, 1996

Risperidone + clozapine effective in chronic schizophrenia

Nov. 8, 1996

New treatment option for schizophrenia approved in Canada

Nov. 8, 1996

Scotia schizophrenia project develops rapidly

Nov. 8, 1996

5-HT1A receptor agonists from Sankyo

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...